Revenue and Deferred Revenue - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Aug. 31, 2019
Deferred Revenue Arrangement [Line Items]
Revenue	$ 4,053	$ 3,312
Deferred revenue	306	133	$ 133	$ 376
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Deferred Revenue Arrangement [Line Items]
Revenue recognized from the remaining performance obligations	$ 3,100
Revenue, remaining performance obligation, percentage	77.00%
Expected remaining performance obligations	12 months
Product
Deferred Revenue Arrangement [Line Items]
Revenue	$ 2,343	2,149
Deferred revenue	100		34
Service
Deferred Revenue Arrangement [Line Items]
Revenue	69	79
Deferred revenue	200		$ 100
Grant | National Institutes of Health
Deferred Revenue Arrangement [Line Items]
Deferred revenue					$ 1,100
Revenue recognized	$ 300	$ 14